Skip to Content

L217 (Lamotrigine (Chewable Dispersible) 5 mg)

Pill with imprint L217 is White, Capsule-shape and has been identified as Lamotrigine (Chewable Dispersible) 5 mg. It is supplied by Alembic Pharmaceuticals Limited.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; borderline personality disorder; epilepsy (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L217

Lamotrigine (Chewable Dispersible)

Imprint:
L217
Strength:
5 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alembic Pharmaceuticals Limited
National Drug Code (NDC):
46708-0095

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide